Artigo Acesso aberto Revisado por pares

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2020; Oxford University Press; Volume: 42; Issue: 5 Linguagem: Inglês

10.1093/eurheartj/ehaa612

ISSN

1522-9645

Autores

Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen J. Bax, Carina Blomström‐Lundqvist, Giuseppe Boriani, Manuel Castellá, Gheorghe‐Andrei Dan, Polychronis Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M. Kalman, Mark La Meir, Deirdre A. Lane, Jean‐Pierre Lebeau, Maddalena Lettino, Gregory Y.H. Lip, Fausto J. Pinto, G. Neil Thomas, Marco Valgimigli, Isabelle C. Van Gelder, Bart P. van Putte, Caroline L Watkins, Paulus Kirchhof, Michael Kühne, Victor Aboyans, Anders Ahlsson, Paweł Balsam, Johann Bauersachs, Stefano Benussi, Axel Brandes, Frieder Braunschweig, A John Camm, Davide Capodanno, Barbara Casadei, David Conen, Harry J.G.M. Crijns, Victoria Delgado, Dobromir Dobrev, Heinz Drexel, Lars Eckardt, Donna Fitzsimons, Thierry Folliguet, Chris P Gale, Bülent Görenek, Karl Georg Hæusler, Hein Heidbüchel, Bernard Iung, Hugo A Katus, Dipak Kotecha, Ulf Landmesser, Christophe Leclercq, Basil S. Lewis, Julia Mascherbauer, José Luís Merino, Béla Merkely, Lluı́s Mont, Christian Mueller, Klaudia Vivien Nagy, Jonas Oldgren, Nikola Pavlović, Roberto F.E. Pedretti, Steffen E. Petersen, Jonathan P. Piccini, Bogdan A. Popescu, Helmut Pürerfellner, Dimitrios J. Richter, Marco Roffi, Andrea Rubboli, Douglas S. Scherr, Renate B. Schnabel, Iain A Simpson, Е. V. Shlyakhto, Moritz F. Sinner, Jan Steffel, Miguel Sousa‐Uva, Piotr Suwalski, Martin Svetlošák, Rhian M. Touyz, Nikolaos Dagres, Elena Arbelo, Jeroen J. Bax, Carina Blomström‐Lundqvist, Giuseppe Boriani, Manuel Castellá, Gheorghe‐Andrei Dan, Polychronis Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M. Kalman, Mark La Meir, Deirdre A. Lane, Jean‐Pierre Lebeau, Maddalena Lettino, Gregory Y.H. Lip, Fausto J. Pinto, G. Neil Thomas, Marco Valgimigli, Isabelle C. Van Gelder, Caroline L Watkins, T. Delassi, Hamayak Sisakian, Douglas S. Scherr, Alexandr Chasnoits, Michel De Pauw, Elnur Smajić, Tchavdar Shalganov, Panayiotis Avraamides, Josef Kautzner, Christian Gerdes, Ahmad Abd Alaziz, Priit Kampus, Pekka Raatikainen, Serge Bovéda, Giorgi Papiashvili, Lars Eckardt, Vassilios Vassilikos, Zoltán Csanádi, Davíð O. Arnar, Joseph Galvin, Alon Barsheshet, Pasquale Caldarola, Amina Rakisheva, Ibadete Bytyçi, Alina Kerimkulova, Oskars Kalējs, Mario Njeim, Aras Puodžiūkynas, Laurent Groben, Mark Sammut, Aurel Grosu, Aneta Bošković, Abdelhamid Moustaghfir, Natasja de Groot, Lidija Poposka, Ole-Gunnar Anfinsen, Przemysław Mitkowski, Diogo Cavaco, Călin Siliște, E. N. Mikhaylov, Luca Bertelli, Dejan Kojić, Róbert Hatala, Zlatko Fras, Fernando Arribas, Tord Juhlin, Christian Sticherling, Leïla Abid, İlyas Atar, O. S. Sychov, Matthew Bates, Н. У. Закиров,

Tópico(s)

Cardiac Imaging and Diagnostics

Resumo

Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It should also read mginstead of mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has also been added to state: Edoxaban should be used in patients with high creatinine clearance only after a careful evaluation of the individual thromboembolic and bleeding risk.Supplementary Table 9, column 'Edoxaban', row 'Dose reduction in selected patients' (page 16). The cell should read Edoxaban 60 mg reduced to 30 mg once daily if any of the following: creatinine clearance 15-50 mL/min, body weight <60 kg, concomitant use of dronedarone, erythromycin, ciclosporine or ketokonazoleinstead of Edoxaban 60 mg reduced to 30 mg once daily, and edoxaban 30 mg reduced to 15mg once daily, if any of the following: creatinine clearance of 30-50 mL/min, body weight <60 kg, concomitant us of verapamil or quinidine or dronedarone.

Referência(s)